Globus Medical (GMED)

Gross profit margin

Dec 31, 2023 Sep 30, 2023 Jun 30, 2023 Mar 31, 2023 Dec 31, 2022 Sep 30, 2022 Jun 30, 2022 Mar 31, 2022 Dec 31, 2021 Sep 30, 2021 Jun 30, 2021 Mar 31, 2021 Dec 31, 2020 Sep 30, 2020 Jun 30, 2020 Mar 31, 2020 Dec 31, 2019 Sep 30, 2019 Jun 30, 2019 Mar 31, 2019
Gross profit (ttm) US$ in thousands 1,020,302 873,161 813,563 793,599 759,118 743,436 725,952 717,944 718,879 703,240 691,074 602,183 571,579 561,900 553,727 605,997 605,393 592,470 573,029 558,227
Revenue (ttm) US$ in thousands 1,568,476 1,226,440 1,096,949 1,068,982 1,022,843 998,366 973,939 961,307 958,102 941,526 927,903 825,809 789,042 767,264 747,381 792,998 785,368 769,639 742,660 721,505
Gross profit margin 65.05% 71.19% 74.17% 74.24% 74.22% 74.47% 74.54% 74.68% 75.03% 74.69% 74.48% 72.92% 72.44% 73.23% 74.09% 76.42% 77.08% 76.98% 77.16% 77.37%

December 31, 2023 calculation

Gross profit margin = Gross profit (ttm) ÷ Revenue (ttm)
= $1,020,302K ÷ $1,568,476K
= 65.05%

Globus Medical Inc's gross profit margin has shown a varying trend over the past eight quarters. The margin decreased from 74.68% in Q1 2022 to 65.05% in Q4 2023, indicating a decline in profitability in the most recent quarter. However, it is worth noting that the gross profit margin was relatively stable at around 74-75% for the majority of the periods analyzed.

The fluctuations in the gross profit margin may be attributable to changes in the cost of goods sold, pricing strategies, or product mix. It is essential for the company to closely monitor and manage its cost structure to ensure sustainable profitability levels.

Additionally, further analysis of the factors impacting gross profit margin, such as operational efficiency, pricing dynamics, and cost management, would provide a more comprehensive understanding of Globus Medical Inc's financial performance.


Peer comparison

Dec 31, 2023